Pleiotropic Effects of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibitors?

被引：28

作者：

Bittner, Vera ^{[1
,2
]}

机构：

[1] Univ Alabama Birmingham, Dept Med, 701 19th St South,LHRB 310, Birmingham, AL 35294 USA

[2] Univ Alabama Birmingham, Div Cardiovasc Dis, 701 19th St South,LHRB 310, Birmingham, AL 35294 USA

来源：

CIRCULATION | 2016年 / 134卷 / 22期

关键词：

lipids; lipoproteins; PCSK9;

D O I：

10.1161/CIRCULATIONAHA.116.023687

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

[No abstract available]

引用

页码：1695 / 1696

页数：2

共 5 条

[1]

PCSK9 in relation to coronary plaque inflammation: Results of the ATHEROREMO-IVUS study [J].

Cheng, Jin M. ;

Oemrawsingh, Rohit M. ;

Garcia-Garcia, Hector M. ;

Boersma, Eric ;

van Geuns, Robert-Jan ;

Serruys, Patrick W. ;

Kardys, Isabella ;

Akkerhuis, K. Martijn .

ATHEROSCLEROSIS, 2016, 248 :117-122

[2]

Efficiency and Safety of Proprotein Convertase Subtilisin/Kexin 9 Monoclonal Antibody on Hypercholesterolemia: A Meta-Analysis of 20 Randomized Controlled Trials [J].

Li, Chuanwei ;

Lin, Ling ;

Zhang, Wen ;

Zhou, Liang ;

Wang, Hongyong ;

Luo, Xiaoli ;

Luo, Hao ;

Cai, Yue ;

Zeng, Chunyu .

JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2015, 4 (06) :e001937

[3]

Proprotein Convertase Subtilisin/Kexin Type 9 Monoclonal Antibodies for Acute Coronary Syndrome A Narrative Review [J].

Navarese, Eliano P. ;

Kolodziejczak, Michalina ;

Kereiakes, Dean J. ;

Tantry, Udaya S. ;

O'Connor, Christopher ;

Gurbel, Paul A. .

ANNALS OF INTERNAL MEDICINE, 2016, 164 (09) :600-+

[4]

PCSK9 inhibition-mediated reduction in Lp(a) with evolocumab: an analysis of 10 clinical trials and the LDL receptor's role [J].

Raal, Frederick J. ;

Giugliano, Robert P. ;

Sabatine, Marc S. ;

Koren, Michael J. ;

Blom, Dirk ;

Seidah, Nabil G. ;

Honarpour, Narimon ;

Lira, Armando ;

Xue, Allen ;

Chiruvolu, Padmaja ;

Jackson, Simon ;

Di, Mei ;

Peach, Matthew ;

Somaratne, Ransi ;

Wasserman, Scott M. ;

Scott, Rob ;

Stein, Evan A. .

JOURNAL OF LIPID RESEARCH, 2016, 57 (06) :1086-1096

[5]

PCSK9 is a critical regulator of the innate immune response and septic shock outcome [J].

Walley, Keith R. ;

Thain, Katherine R. ;

Russell, James A. ;

Reilly, Muredach P. ;

Meyer, Nuala J. ;

Ferguson, Jane F. ;

Christie, Jason D. ;

Nakada, Taka-aki ;

Fjell, Chris D. ;

Thair, Simone A. ;

Cirstea, Mihai S. ;

Boyd, John H. .

SCIENCE TRANSLATIONAL MEDICINE, 2014, 6 (258) :258ra143

← 1 →